Fueling bold approaches

Flu Lab's mission is to eliminate the threat of influenza, a highly contagious virus that causes annual epidemics of disease and poses an ever-present risk of a catastrophic pandemic. To achieve this, Flu Lab finds and supports efforts that approach persistent problems in new and dynamic ways, with actionable results.

Awarded Grants

Flu Lab and the organizations it supports collectively work to enhance and expand the influenza ecosystem, and to stimulate and accelerate research and translation of discoveries into applied technologies, strategies, and medical countermeasures. We are pleased to showcase past and current grantees.


University of Oxford

Evaluating treatments for severe and complicated influenza infections in hospitalized patients with RECOVERY FLU, a cost-efficient, adaptive platform clinical trial.

£11,416,263 / December 2022


Kansas State University and Icahn School of Medicine

Establishing a swine herd model for assessing efficacy of broadly protective influenza virus vaccines.

$1,652,929 / December 2022


University of Auckland

Leads a multidisciplinary and collaborative effort to observe and examine the reintroduction and transmission of influenza in New Zealand and identify novel immunological markers to inform influenza vaccine development.

11,340,572 NZD / December 2022, May 2021

RM + AUH UK logo ver2.jpg

Aarhus University Hospital

Leads INVITED, a multicenter, prospective randomized clinical trial among Type 1 diabetes patients to improve our understanding of the protective effect of influenza vaccination.

2,382,555 DKK / October 2022

Protas_Logo_900_x_450px copy.jpg


Reducing barriers to better treatments by designing and delivering high-quality, large-scale and global clinical trials at a fraction of current industry cost.

£5,000,000 / October 2022


NYC Virus Hunters

Creates an immersive approach to science education to unlock the potential of the next generation of influenza researchers in New York City.

$1,146,303 / July 2022, April 2020

Univ. of PA.png

Behavior Change for Good Initiative

Leverages the expertise of over 100 behavioral scientists to identify effective, scalable interventions for promoting immunizations.

$2,435,763 / March 2022, June 2021, October 2020


Virgina Tech

Leads the Multidisciplinary InvesTIGAtion of Transmission to Ease inFLUenza (MITIGATE FLU) study to transform our understanding of influenza virus transmission.

$8,792,291 / February 2022


University of California, Davis

Optimizing ventilation system operations to minimize airborne infectious disease transmission, pollutant exposure, and energy consumption.

$327,539 / November 2021

green schools.png

Center for Green Schools

Equips schools and education stakeholders with information and guidance to improve ventilation and air filtration in classrooms.

$855,710 / October 2021, August 2021


Center for Open Science

Leads multiple initiatives to promote open science and expand the publication of null and negative influenza research findings and replication studies.

$18,398,983 / August 2021, April 2020, August 2019


Influenzer Initiative

Brings diverse thinkers and disciplines together to identify big ideas and promote pathways to accelerating universal influenza vaccine development.

$8,900,000 / June 2021, January 2018


University of Cambridge

Pursuing a novel, host-directed approach to a universal influenza vaccine.

$904,384 / June 2021


Association of Immunization Managers

Brought together immunization managers and school nurses to identify replicable best practices for school-located vaccination programs.

$208,035 / June 2021


The Grand Challenge for Universal Influenza Vaccine Development

Supports eight teams developing novel, transformative approaches to universal influenza vaccines (in partnership with the Bill & Melinda Gates Foundation)

$6,215,453 / April 2021, January 2021, August 2019


Public Health Aerobiology, Virology, and Exhaled Biomarker Lab

Leads a research agenda centered on influenza transmission and the interplay between influenza and SARS-CoV-2 viruses.

$2,539,000 / March 2021


Sentinel Project

Develops ultra-sensitive genomic and CRISPR technologies to detect pathogens in multiple, connected settings to prevent pandemics before they start.

$5,000,000 / February 2021

African center.jpg

Sentinel Project

Combines diagnostic technology and information-sharing platforms to connect early warning data to the public health community.

$11,250,000 / December 2020


Imperial College London and Princeton University

Assessing performance characteristics and market dynamics of universal influenza vaccines using mathematical modeling methods.

$381,199 / November 2020


Stanford Healthcare Innovation Lab

Demonstrated the utility of wearables for early disease signaling, before symptoms emerge.

$1,870,000 / October 2020, August 2020


Outbreaks Near Me

Provides a crowdsourced infectious disease surveillance system to provide early outbreak warnings for communities and local public health agencies.

$1,005,451 / August 2020



Developed and examined a novel strategy for disease surveillance that improves representativeness of population samples.

$230,000 / August 2020


Berkeley, Public Health

Evaluated the direct and indirect health impacts of a school-based seasonal influenza vaccination program in the Bay Area.

$278,422 / August 2020, February 2020, February 2019


Community Epidemiology in Action

Created an open source, anonymous, privacy-first symptom sharing and exposure alerting application to help communities of close contacts protect themselves.

$100,000 / May 2020

Venture Investments

Flu Lab invests in ambitious and innovative companies that are developing solutions to our greatest influenza challenges. For news and updates about our investments, visit News + More.



Develops fast, accurate, and affordable molecular tests for routine use by everyone including consumers in the home, employees in the workplace, and students at school.


GreenLight Biosciences

Offers an inexpensive, self-contained, and scalable mRNA manufacturing platform for vaccines targeting infectious diseases including influenza and COVID-19.



Leverages a network of millions of smart thermometers to provide infectious illness signaling capacity and data insights for schools, health systems, states, cities, and enterprises.

Covid-19 Giving

Flu Lab expanded our grantmaking to support efforts to respond to the profound health, social, and economic impacts of the COVID-19 pandemic. The following organizations made a difference during this crisis.


C19 Coalition

Built an efficient and unified supply chain and financing opportunities for PPE and lifesaving medical devices.



Fast Grants

Developed an approach to funding COVID-19 scientific research that values rigor, flexibility and speed.




Built breakthrough approaches to delivering cash relief to vulnerable people in the U.S. and Africa.



Heluna Health COVID-19 Response Fund

Supported population health programs across California working to respond to the COVID-19 crisis.



Next Door Solutions

Supported the expanded service needs of Bay Area domestic violence victims and survivors.



Partners in Health

Expanded the capacity of local public health department contact tracing efforts.



Project ECHO

Created clinical care knowledge exchange networks among global experts and frontline healthcare workers.



Restaurants for the People

Provided food security for people in need and kept small restaurants and food businesses open.



COVID-19 Solidarity Response Fund

Supported WHO coordination of the global response to the COVID-19 pandemic.


Funding Opportunities

Flu Lab promotes innovation to speed the advancement of technologies and approaches for influenza, and we are open to receiving unsolicited pre-proposals at info@theflulab.org. See below for funding opportunities.


Call for Negative & Null Results and Replication of Important Findings

Apply Now

Description: Publication bias negatively shapes and limits our understanding of influenza and results in wasted resources, missed insights, and lost time. Flu Lab has partnered with the Center for Open Science and the Public Library of Science (PLOS) to expand the publication of null and negative research findings. Researchers are invited to submit proposals, and if eligible, proposals may be awarded up to $25,000 to support the research design, manuscript development, and publishing processes.